By: dokae
https://unsplash.com/photos/people-walking-through-a-bustling-japanese-shopping-arcade-n5Prgkv-bMY
🌎 일본 오사카부 오사카시
📸 RICOH IMAGING COMPANY, LTD., GR II
18.3mm ƒ/2.8
1/60s
ISO 100
#retail #streetPhotography #peopleWalking #foodAndDrink #streetFood
https://unsplash.com/photos/people-walking-through-a-bustling-japanese-shopping-arcade-n5Prgkv-bMY
🌎 일본 오사카부 오사카시
📸 RICOH IMAGING COMPANY, LTD., GR II
18.3mm ƒ/2.8
1/60s
ISO 100
#retail #streetPhotography #peopleWalking #foodAndDrink #streetFood
January 28, 2026 at 2:00 AM
By: dokae
https://unsplash.com/photos/people-walking-through-a-bustling-japanese-shopping-arcade-n5Prgkv-bMY
🌎 일본 오사카부 오사카시
📸 RICOH IMAGING COMPANY, LTD., GR II
18.3mm ƒ/2.8
1/60s
ISO 100
#retail #streetPhotography #peopleWalking #foodAndDrink #streetFood
https://unsplash.com/photos/people-walking-through-a-bustling-japanese-shopping-arcade-n5Prgkv-bMY
🌎 일본 오사카부 오사카시
📸 RICOH IMAGING COMPANY, LTD., GR II
18.3mm ƒ/2.8
1/60s
ISO 100
#retail #streetPhotography #peopleWalking #foodAndDrink #streetFood
春の如く 9
Blossom Dearie - It Might As Well Be Spring
ブロッサム・ディアリー - 春の如く
from the album "Blossom Dearie"（1957/04）
www.youtube.com/watch?v=-BmY...
Blossom Dearie - It Might As Well Be Spring
ブロッサム・ディアリー - 春の如く
from the album "Blossom Dearie"（1957/04）
www.youtube.com/watch?v=-BmY...
It Might As Well Be Spring
YouTube video by Blossom Dearie - Topic
www.youtube.com
January 26, 2026 at 3:08 PM
春の如く 9
Blossom Dearie - It Might As Well Be Spring
ブロッサム・ディアリー - 春の如く
from the album "Blossom Dearie"（1957/04）
www.youtube.com/watch?v=-BmY...
Blossom Dearie - It Might As Well Be Spring
ブロッサム・ディアリー - 春の如く
from the album "Blossom Dearie"（1957/04）
www.youtube.com/watch?v=-BmY...
#BiotechHangout Grace Colon, Tim Opler, Graig Suvannavejh, Eric Schmidt on biopharma market outlook & sentiment, bull/bear debate, IPOs, deals: #$GSK / #$RAPT, #$JANX / #$BMY, policy: US exits WHO, NDAA bill updates for biotech, FDA myeloma guidelines, & #$CRVS data & women’s health report bit.ly/4r3fGlY
January 23, 2026 at 3:59 PM
#BiotechHangout Grace Colon, Tim Opler, Graig Suvannavejh, Eric Schmidt on biopharma market outlook & sentiment, bull/bear debate, IPOs, deals: #$GSK / #$RAPT, #$JANX / #$BMY, policy: US exits WHO, NDAA bill updates for biotech, FDA myeloma guidelines, & #$CRVS data & women’s health report bit.ly/4r3fGlY
#$PFE slowly building up towards a breakout. Looks ready. Algos treat it like a vaccine stock, and all the other ones have moved. See #$MRNA, #$NVAX, #$BNTX. Alternative is seeing as a pharma major, and those also moved. See #$MRK, #$REGN, #$BMY and others. I think it's "scheduled" to pop on earnings.
January 23, 2026 at 8:04 AM
#$PFE slowly building up towards a breakout. Looks ready. Algos treat it like a vaccine stock, and all the other ones have moved. See #$MRNA, #$NVAX, #$BNTX. Alternative is seeing as a pharma major, and those also moved. See #$MRK, #$REGN, #$BMY and others. I think it's "scheduled" to pop on earnings.
Morningstar advises undervalued blue-chip stocks with wide moats for long-term holds (into 2026). Top picks: $MSFT (AI, cloud, network effects) and $BMY (strong drug pipeline, mitigates patent woes). Both $100B+ and undervalued. #stocks #investing #BuffQuant
January 21, 2026 at 6:10 PM
Morningstar advises undervalued blue-chip stocks with wide moats for long-term holds (into 2026). Top picks: $MSFT (AI, cloud, network effects) and $BMY (strong drug pipeline, mitigates patent woes). Both $100B+ and undervalued. #stocks #investing #BuffQuant
Microsoft has partnered with Bristol Myers to implement FDA-cleared radiology AI algorithms through Microsoft’s Precision Imaging Network.
#MSFT #BMY #Microsoft #AI #MedTech
#MSFT #BMY #Microsoft #AI #MedTech
January 21, 2026 at 3:30 PM
Microsoft has partnered with Bristol Myers to implement FDA-cleared radiology AI algorithms through Microsoft’s Precision Imaging Network.
#MSFT #BMY #Microsoft #AI #MedTech
#MSFT #BMY #Microsoft #AI #MedTech
#BMS #BMY Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
https://www.stocktitan.net/news/BMS/bristol-myers-squibb-announces-collaboration-with-microsoft-to-8g3sopjaul8l.html
https://www.stocktitan.net/news/BMS/bristol-myers-squibb-announces-collaboration-with-microsoft-to-8g3sopjaul8l.html
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
Bristol Myers Squibb (NYSE: BMS) announced a collaboration with Microsoft on January 20, 2026 to deploy U.S. FDA-cleared radiology AI algorithms for lung cancer detection via Microsoft’s Precision Imaging Network. The initiative aims to automatically analyze X-ray and CT images to surface hard-to-detect lung nodules, accelerate identification of potential Non‑Small Cell Lung Cancer (NSCLC) cases, and route patients into care pathways.The program emphasizes expanding early detection and follow-up in medically underserved communities, leveraging workflow tools to address that >50% of patients with incidental findings are lost to follow-up and noting Microsoft’s network reaches more than 80% of U.S. hospitals.
www.stocktitan.net
January 20, 2026 at 11:59 AM
#BMS #BMY Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
https://www.stocktitan.net/news/BMS/bristol-myers-squibb-announces-collaboration-with-microsoft-to-8g3sopjaul8l.html
https://www.stocktitan.net/news/BMS/bristol-myers-squibb-announces-collaboration-with-microsoft-to-8g3sopjaul8l.html
Buy $BMY (BMY.N) @ 11:59:05
January 20, 2026 at 11:59 AM
Buy $BMY (BMY.N) @ 11:59:05
#BiotechHangout: Chris Garabedian, Mike Yee, Paul Matteis, Sam Fazeli will recap #JPM26, 2026 kickoff, VC investing, company news: #$ALNY, #$MRNA, deals: #$ABBV, AI, regulatory: FDA updates, #$ATRA, obesity: #$LLY, #$AMGN, #$ABBV, #$BMY, other data: #$LXEO, #$BMRN, #$JNJ, #$VRTX & #$SION, #$LLY: bit.ly/3Zg2m1H
January 16, 2026 at 2:51 PM
#BiotechHangout: Chris Garabedian, Mike Yee, Paul Matteis, Sam Fazeli will recap #JPM26, 2026 kickoff, VC investing, company news: #$ALNY, #$MRNA, deals: #$ABBV, AI, regulatory: FDA updates, #$ATRA, obesity: #$LLY, #$AMGN, #$ABBV, #$BMY, other data: #$LXEO, #$BMRN, #$JNJ, #$VRTX & #$SION, #$LLY: bit.ly/3Zg2m1H
BMS taps Immunai's AI platform for immune insights $BMY firstwordpharma.com/story/7065872
January 16, 2026 at 3:36 AM
BMS taps Immunai's AI platform for immune insights $BMY firstwordpharma.com/story/7065872
Here are my LEAPS expiring tomorrow
APA 25’s i paid $10 worth $1
BMY 60s i paid $3 worth 0
PCG 15s paid $2.5 worth $1
TSM100spaid$29worth$225
Brkb200spaid$188wrth$294
The BRKB in the money calls has been a regular roll. Low vol makes for a lot of cheap leverage. Steady compounder. But now no WB…
APA 25’s i paid $10 worth $1
BMY 60s i paid $3 worth 0
PCG 15s paid $2.5 worth $1
TSM100spaid$29worth$225
Brkb200spaid$188wrth$294
The BRKB in the money calls has been a regular roll. Low vol makes for a lot of cheap leverage. Steady compounder. But now no WB…
January 15, 2026 at 12:51 PM
Here are my LEAPS expiring tomorrow
APA 25’s i paid $10 worth $1
BMY 60s i paid $3 worth 0
PCG 15s paid $2.5 worth $1
TSM100spaid$29worth$225
Brkb200spaid$188wrth$294
The BRKB in the money calls has been a regular roll. Low vol makes for a lot of cheap leverage. Steady compounder. But now no WB…
APA 25’s i paid $10 worth $1
BMY 60s i paid $3 worth 0
PCG 15s paid $2.5 worth $1
TSM100spaid$29worth$225
Brkb200spaid$188wrth$294
The BRKB in the money calls has been a regular roll. Low vol makes for a lot of cheap leverage. Steady compounder. But now no WB…
Biopharma bites: Teva, Kinaset pull in funds, Camzyos wins in teens, plus contrasting fortunes for Lynk, Lyra $TEVA $BMY $LYRA firstwordpharma.com/story/7061231
January 12, 2026 at 9:49 PM
Biopharma bites: Teva, Kinaset pull in funds, Camzyos wins in teens, plus contrasting fortunes for Lynk, Lyra $TEVA $BMY $LYRA firstwordpharma.com/story/7061231
Buy $BMY (BMY.N) @ 11:59:00
January 12, 2026 at 11:59 AM
Buy $BMY (BMY.N) @ 11:59:00
rubbing bmy shins and calves
January 10, 2026 at 2:36 AM
rubbing bmy shins and calves
Is Bristol Myers Squibb (BMY) Quietly Recasting Its Post-Patent Story With Opdivo And KarXT Moves? - simplywall.st: Is Bristol Myers Squibb (BMY) Quietly Recasting Its Post-Patent Story With Opdivo And KarXT Moves? simplywall.st
Is Bristol Myers Squibb (BMY) Quietly Recasting Its Post-Patent Story With Opdivo And KarXT Moves? - simplywall.st
Is Bristol Myers Squibb (BMY) Quietly Recasting Its Post-Patent Story With Opdivo And KarXT Moves? simplywall.st
simplywall.st
January 8, 2026 at 6:34 AM
Is Bristol Myers Squibb (BMY) Quietly Recasting Its Post-Patent Story With Opdivo And KarXT Moves? - simplywall.st: Is Bristol Myers Squibb (BMY) Quietly Recasting Its Post-Patent Story With Opdivo And KarXT Moves? simplywall.st
There are 33 companies in the S&P 500 & NASDAQ 100 that that are Overbought based on RSI today: $ADI, $ALB, $AMAT, $BA, $BMY, $CMG, $CNC, $CRL, $DG, $FCX, $FDX, $FOX, $HAS, $INCY, $IQV, $LRCX, $LUV, $MCHP, $MRK, $MU, $NCLH, $NDAQ, $NDSN, $ON, $ROST, $SNDK, $SNPS, $TMO, $ULTA, $UPS, $VRTX, $VTRS,
January 7, 2026 at 11:02 PM
There are 33 companies in the S&P 500 & NASDAQ 100 that that are Overbought based on RSI today: $ADI, $ALB, $AMAT, $BA, $BMY, $CMG, $CNC, $CRL, $DG, $FCX, $FDX, $FOX, $HAS, $INCY, $IQV, $LRCX, $LUV, $MCHP, $MRK, $MU, $NCLH, $NDAQ, $NDSN, $ON, $ROST, $SNDK, $SNPS, $TMO, $ULTA, $UPS, $VRTX, $VTRS,
Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Opdivo And Eliquis Patent Cliff Risks - Yahoo Finance: Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Opdivo And Eliquis Patent Cliff Risks Yahoo Finance
Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Opdivo And Eliquis Patent Cliff Risks - Yahoo Finance
Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Opdivo And Eliquis Patent Cliff Risks Yahoo Finance
finance.yahoo.com
January 7, 2026 at 10:50 PM
Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Opdivo And Eliquis Patent Cliff Risks - Yahoo Finance: Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Opdivo And Eliquis Patent Cliff Risks Yahoo Finance
$BMY $IMCR $ALB $AQN $HSY $LOW $MCD $NOK $W -- THE WSJ
January 7, 2026 at 3:42 PM
$BMY $IMCR $ALB $AQN $HSY $LOW $MCD $NOK $W -- THE WSJ
Early👀1-7-26
Sp-1, Naz-41, DJI+55
10-yr 4.13% JGB10 2.12%
Crude-.63%, Gold -1%, SLV -4.4%
BTC-.44%
UP: ALB, AMC, AQN, BMY, FCF,
HSY, LOW, MCD, REGN, SHW,
PEG, VOD, W, XYZ
DN: AFYA, AJG, BAC, BJ, BBAI, CFG,
CLF, CROX, DECK, DHI, FSLR,
HUM, JPM, LEN, LYB, MTB, PB,
UHS, UNP, USB, WRB, WWW, YUM
Sp-1, Naz-41, DJI+55
10-yr 4.13% JGB10 2.12%
Crude-.63%, Gold -1%, SLV -4.4%
BTC-.44%
UP: ALB, AMC, AQN, BMY, FCF,
HSY, LOW, MCD, REGN, SHW,
PEG, VOD, W, XYZ
DN: AFYA, AJG, BAC, BJ, BBAI, CFG,
CLF, CROX, DECK, DHI, FSLR,
HUM, JPM, LEN, LYB, MTB, PB,
UHS, UNP, USB, WRB, WWW, YUM
January 7, 2026 at 1:51 PM
Early👀1-7-26
Sp-1, Naz-41, DJI+55
10-yr 4.13% JGB10 2.12%
Crude-.63%, Gold -1%, SLV -4.4%
BTC-.44%
UP: ALB, AMC, AQN, BMY, FCF,
HSY, LOW, MCD, REGN, SHW,
PEG, VOD, W, XYZ
DN: AFYA, AJG, BAC, BJ, BBAI, CFG,
CLF, CROX, DECK, DHI, FSLR,
HUM, JPM, LEN, LYB, MTB, PB,
UHS, UNP, USB, WRB, WWW, YUM
Sp-1, Naz-41, DJI+55
10-yr 4.13% JGB10 2.12%
Crude-.63%, Gold -1%, SLV -4.4%
BTC-.44%
UP: ALB, AMC, AQN, BMY, FCF,
HSY, LOW, MCD, REGN, SHW,
PEG, VOD, W, XYZ
DN: AFYA, AJG, BAC, BJ, BBAI, CFG,
CLF, CROX, DECK, DHI, FSLR,
HUM, JPM, LEN, LYB, MTB, PB,
UHS, UNP, USB, WRB, WWW, YUM
📊 🎯 Rotation tape: analyst action is driving dispersion—defensive Healthcare bid (UBS upgrades) vs renewed caution in Solar/Consumer Discretionary on downgrades as futures tick down slightly.
UBS turns constructive on Pharma: $BMY upgraded to Buy with PT raised to $65 from $46; $LLY initiated
UBS turns constructive on Pharma: $BMY upgraded to Buy with PT raised to $65 from $46; $LLY initiated
January 7, 2026 at 1:34 PM
📊 🎯 Rotation tape: analyst action is driving dispersion—defensive Healthcare bid (UBS upgrades) vs renewed caution in Solar/Consumer Discretionary on downgrades as futures tick down slightly.
UBS turns constructive on Pharma: $BMY upgraded to Buy with PT raised to $65 from $46; $LLY initiated
UBS turns constructive on Pharma: $BMY upgraded to Buy with PT raised to $65 from $46; $LLY initiated